METHYLENE BLUE 1% 30ML

Unlock the Potential of 1% Methylene Blue Solution

Only for research purposes

Embark on a journey towards enhanced well-being with our premium-grade 1% Methylene Blue solution. Offering a convenient and ready-to-use form of this versatile compound. 

Convenient Measuring Tool Included: Each order includes a precise graduated dropper, aiding in accurate measurements.

About Methylene Blue:

USP-grade Methylene Blue has a long history of usage in various fields, including medicine, biochemistry, and environmental science. Renowned for its potent antioxidant properties, 1% methylene blue effectively neutralizes harmful free radicals, protecting cells from oxidative stress and potential damage.

Summary of Research Findings Published by American National Library of Medicine:

• Antioxidant Powerhouse: Methylene blue acts as a shield against free radicals, the destructive molecules that contribute to cellular aging and chronic diseases. Its antioxidant prowess safeguards cells, tissues, and organs from oxidative damage, promoting overall health and longevity.

• Neuroprotective Defenses: Methylene blue emerges as a promising agent in the realm of neuroprotection. Its ability to enhance mitochondrial function and modulate inflammation offers potential therapeutic benefits in the treatment of neurodegenerative disorders like Alzheimer's disease, Parkinson's disease, and multiple sclerosis.

• Mood Enhancement: Methylene blue's impact on the brain extends beyond its neuroprotective properties. Studies suggest that it may play a role in regulating mood and managing symptoms of depression and anxiety. Its ability to modulate neurotransmitter activity and promote dopamine signaling hints at its potential as an adjunct therapy for mood disorders.

• Skin Care Benefits: Methylene blue exhibits remarkable protective properties for the skin. Its ability to counteract oxidative stress and shield skin cells from the damaging effects of ultraviolet radiation makes it a promising candidate for anti-aging and sun protection formulations.

• Additional Potentials: Methylene blue's versatility extends beyond its antioxidant and neuroprotective properties. It holds promise in treating various conditions, including cyanide poisoning, carbon monoxide poisoning, and malaria. Ongoing research continues to unveil its multifaceted potential in various therapeutic applications.

Recommendations:

Methylene Blue is primarily intended for research and laboratory applications. For personal or medical use, it is essential to consult a healthcare professional to determine the appropriate dosage and application method.

Embrace the power of Methylene Blue and embark on a journey towards enhanced well-being. With its remarkable antioxidant, neuroprotective, and mood-enhancing properties, this versatile compound holds the potential to unlock a world of wellness.

https://pubmed.ncbi.nlm.nih.gov/27351678

https://pubmed.ncbi.nlm.nih.gov/27284082

https://content.iospress.com/articles/journal-of-alzheimers-disease/ jad190772 

Study : Superior Outcomes with Methylene Blue Monotherapy in Alzheimer's Patients 

Link: https://content.iospress.com/articles/journal-of-alzheimers-disease/ jad170560

Participants: Clinical trial with 795 Alzheimer's patients Key Findings: Patients receiving MB as monotherapy had consistently better cognitive outcomes than those receiving it alongside cholinesterase inhibitors or memantine. The monotherapy group showed a 38% improvement in cognitive scores compared to the combination therapy group.

Study : Methylene Blue Treatment Benefits in Moderate Alzheimer's Disease 

Link: https://content.iospress.com/articles/journal-of-alzheimers-disease/ jad142874

Participants: Clinical trial with 321 participants Key Findings: After 24 weeks of treatment with a daily dose of 138 mg of MB, patients with moderate Alzheimer's disease showed a 4.1-point improvement on the ADAS-cog scale compared to placebo, indicating significant cognitive benefits.

Study : Efficacy of Methylene Blue in Mild to Moderate Alzheimer's Disease 

Link: https://alz-journals.onlinelibrary.wiley.com/doi/10.1016/ j.jalz.2008.05.438

Participants: Clinical trial with 332 participants Key Findings: At a 60 mg dose, MB produced a significant improvement versus the placebo group. The effect size was a 5.8-point difference on the ADAS-cog scale, reflecting a 68% improvement over placebo.

Study : Methylene Blue Reduces Incidence of Early Postoperative Cognitive Disorders 

Link: https://www.sciencedirect.com/science/article/abs/pii/ S0952818020318262?via%3Dihub

Participants: Clinical study with elderly surgical patients Key Findings: MB administration resulted in a 60% reduction in the incidence of early postoperative cognitive disorders among elderly patients, highlighting its significant neuroprotective effects during surgery.

Study : Methylene Blue Modulates Functional Connectivity in the Human Brain 

Link: https://link.springer.com/article/10.1007/s11682-016-9541-6

Participants: Human study with 32 healthy adults Key Findings: The study found that MB increased functional MRI signals in brain regions associated with memory and attention by up to 20%, indicating its potential cognitive enhancement properties.